Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Katherine G. Roth"'
1
Determinants of Psychosocial Distress in Breast Cancer Patients at a Safety Net Hospital
Autor: Danielle M. Hari, Jessica K. Liu, Junko Ozao-Choy, Christine Dauphine, Katherine G. Roth, Kathryn T. Chen, James Yeh, Amy H. Kaji
Publikováno v: Clinical Breast Cancer. 22:43-48
Psychosocial distress screening of cancer patients is an American College of Surgeons Commission on Cancer mandate for accredited cancer programs. We evaluated psychosocial distress in breast cancer patients to characterize risk factors for high dist
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5ceac41cc429b4a93de58a8bfacc64
https://doi.org/10.1016/j.clbc.2021.06.011
Zobrazit plný text záznamu
2
The Mitochondrion as an Emerging Therapeutic Target in Cancer
Autor: Isa Mambetsariev, Ravi Salgia, Prakash Kulkarni, Katherine G. Roth
Publikováno v: Trends Mol Med
Mitochondria have emerged as important pharmacological targets because of their key role in cellular proliferation and death. In tumor tissues, mitochondria can switch metabolic phenotypes to meet the challenges of high energy demand and macromolecul
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616147ff95ef3d7e05e9b30e97740fef
https://doi.org/10.1016/j.molmed.2019.06.009
Zobrazit plný text záznamu
3
Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring
Autor: Katherine G, Roth, Isa, Mambetsariev, Ravi, Salgia
Publikováno v: Cold Spring Harbor Molecular Case Studies
Tyrosine kinase inhibitors (TKIs) have transformed the standard of care in lung cancer. A number of TKIs have been discovered that specifically target oncogenes, including MET receptor tyrosine kinase. Second-generation MET TKIs are showing improved
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::eaef456a6553e50937a7aca592f71255
https://pubmed.ncbi.nlm.nih.gov/33335011
Zobrazit plný text záznamu
5
Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring MET exon 14 mutation: a research report
Autor: Katherine G. Roth, Ravi Salgia, Isa Mambetsariev
Publikováno v: Molecular Case Studies. 6:a005785
Tyrosine kinase inhibitors (TKIs) have transformed the standard of care in lung cancer. A number of TKIs have been discovered that specifically target oncogenes, including MET receptor tyrosine kinase. Second-generation MET TKIs are showing improved
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86e28b8d8310bbce0989840c15c0d3ed
https://doi.org/10.1101/mcs.a005785
Zobrazit plný text záznamu
7
Cancer Risk Communication with Low Health Literacy Patients: A Continuing Medical Education Program
Autor: Lisa A. Cooper, Kit Shelby, Katherine G. Roth, Eboni G. Price-Haywood
Publikováno v: Journal of General Internal Medicine. 25:126-129
Low health literacy (HL) is an important risk factor for cancer health disparities.Describe a continuing medical education (CME) program to teach primary care physicians (PCP) cancer risk communication and shared decision-making (SDM) with low HL pat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::264732586e61107bd61c6e52844ede42
https://doi.org/10.1007/s11606-009-1211-6
Zobrazit plný text záznamu
8
WP760, a melanoma selective drug
Autor: Elizabeth A. Grimm, Waldemar Priebe, Mikyung Han, Sangkyou Lee, Nancy Poindexter, Izabela Fokt, Katherine G. Roth, Mingzhong Zheng, Eugene T. Walch, Chi Hui Tang
Publikováno v: Cancer Chemotherapy and Pharmacology. 60:625-633
Our goal was to perform studies on the specificity and antimelanoma mechanism of a novel bis-anthracycline, WP760. WP760 initially identified in the NCI 160 screen as anti-melanoma.The methyl thiazolyl tetrazolium reduction (MTT) assay was used to te
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39c5e816f6bea125d2a48e52dbcf1d20
https://doi.org/10.1007/s00280-006-0404-5
Zobrazit plný text záznamu
9
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort
Autor: Meredith A. Mills, Julie O. Culver, Charité Ricker, Stephen B. Gruber, Brian Allen, Katherine G Roth, Christine Hong, Kerry Kingham, Uri Ladabaum, Nicolette M. Chun, Allison W. Kurian, Anne-Renee Hartman, Gregory Idos, Kevin McDonnell, Brent Evans, Rachel Koff, Courtney Rowe-Teeter, Duveen Sturgeon, Leah Naghi, James M. Ford
Publikováno v: Journal of Clinical Oncology. 35:1523-1523
1523 Background: Mutation carrier prediction models are clinically useful tools for identifying candidates for genetic counseling and testing. Consensus guidelines recommend germline genetic testing for those with a carrier probability (CP) of approx
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fad826ccdc91cabb3f98b7e8fa5d1295
https://doi.org/10.1200/jco.2017.35.15_suppl.1523
Zobrazit plný text záznamu
10
Impact of AJCC 'T' designation on risk of regional lymph node metastasis in patients with squamous carcinoma of the eyelid
Autor: Tarek El Sawy, Qasiem J. Nasser, Carla L. Warneke, Katherine G. Roth, Vivian T. Yin, Bita Esmaeli
Publikováno v: The British journal of ophthalmology. 98(4)
Background/aims Squamous cell carcinoma (SCC) of eyelid is the second most common cancer of the eyelid with the potential for nodal metastasis. The purpose of this report is to determine whether primary tumour size and ‘T’ designation in the Amer
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1acac2973d5e231de269408add957211
https://pubmed.ncbi.nlm.nih.gov/24429279
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje